secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001193125-24-062338
Event type: earnings
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies reports FY2023 net loss $72.7M; cash $141.4M; substantial doubt about going concern
--------------------------------------------------------------------------------

- Net loss $72.7M ($0.76/share) vs $96.3M in 2022; operating expenses $92.2M, with R&D $60.2M.
- Cash and equivalents $141.4M as of Dec 31, 2023, down from $209.2M; projected to fund operations only through Dec 31, 2024.
- VITESSE Phase 3 trial for ages 4-7: last patient screening expected Q3 2024; COMFORT Toddlers and Children safety trials to initiate.
- Substantial doubt about ability to continue as going concern; company intends to seek additional debt and equity capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312524062338/0001193125-24-062338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312524062338/d799764d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-062338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer